Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Pascal Claudepierre

Showing results (21-30 of 154) with videos related to

Pageof 16
Sort By:
Joint Bone Spine|July 12, 2015
Spondyloarthritis: A concept or a disease?Daniel Wendling, Pascal Claudepierre, Clément Prati, et al.
Clinical and Experimental Rheumatology|September 6, 2018
Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-α blockers treatmentBhowmik Meghnathi, Pascal Claudepierre, Maxime Dougados, et al.
Joint Bone Spine|February 13, 2009
A plea for reason in using magnetic resonance imaging for the diagnostic and therapeutic management of spondyloarthropathiesPhilippe Goupille, Thao Pham, Pascal Claudepierre, et al.
RMD Open|August 8, 2024
Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS)Laura Pina Vegas, Siham Iggui, Emilie Sbidian, et al.
Rheumatology (Oxford, England)|September 10, 2020
Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance databaseLaura Pina Vegas, Emilie Sbidian, Laetitia Penso, et al.
Annals of the Rheumatic Diseases|December 1, 2019
Clinical manifestations, disease activity and disease burden of radiographic versus non-radiographic axial spondyloarthritis over 5 years of follow-up in the DESIR cohortClementina López-Medina, Anna Molto, Pascal Claudepierre, et al.
JAMA Dermatology|March 23, 2022
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance DatabaseLaura Pina Vegas, Laetitia Penso, Pascal Claudepierre, et al.
The Journal of Rheumatology|February 12, 2009
Marked regression of pulmonary rheumatoid nodules under etanercept therapyGaelle Derot, Andre Marini-Portugal, Bernard Maitre, et al.
RMD Open|December 19, 2023
Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis: a cohort study of 14 778 patients from the French health insurance database (SNDS)Laura Pina Vegas, Laetitia Penso, Emilie Sbidian, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2014
Effectiveness of tumor necrosis factor α blockers in early axial spondyloarthritis: data from the DESIR cohortAnna Moltó, Simon Paternotte, Pascal Claudepierre, et al.
Pageof 16

Showing results (21-30 of 154) with videos related to

Sort By:
Pageof 16
Joint Bone Spine|July 12, 2015
Spondyloarthritis: A concept or a disease?Daniel Wendling, Pascal Claudepierre, Clément Prati, et al.
Clinical and Experimental Rheumatology|September 6, 2018
Evaluation of extreme patient-reported outcome in early spondyloarthritis and its impact on the effect of TNF-α blockers treatmentBhowmik Meghnathi, Pascal Claudepierre, Maxime Dougados, et al.
Joint Bone Spine|February 13, 2009
A plea for reason in using magnetic resonance imaging for the diagnostic and therapeutic management of spondyloarthropathiesPhilippe Goupille, Thao Pham, Pascal Claudepierre, et al.
RMD Open|August 8, 2024
Impact of initiation of targeted therapy on the use of psoriatic arthritis-related treatments and healthcare consumption: a cohort study of 9793 patients from the French health insurance database (SNDS)Laura Pina Vegas, Siham Iggui, Emilie Sbidian, et al.
Rheumatology (Oxford, England)|September 10, 2020
Epidemiologic study of patients with psoriatic arthritis in a real-world analysis: a cohort study of the French health insurance databaseLaura Pina Vegas, Emilie Sbidian, Laetitia Penso, et al.
Annals of the Rheumatic Diseases|December 1, 2019
Clinical manifestations, disease activity and disease burden of radiographic versus non-radiographic axial spondyloarthritis over 5 years of follow-up in the DESIR cohortClementina López-Medina, Anna Molto, Pascal Claudepierre, et al.
JAMA Dermatology|March 23, 2022
Long-term Persistence of First-line Biologics for Patients With Psoriasis and Psoriatic Arthritis in the French Health Insurance DatabaseLaura Pina Vegas, Laetitia Penso, Pascal Claudepierre, et al.
The Journal of Rheumatology|February 12, 2009
Marked regression of pulmonary rheumatoid nodules under etanercept therapyGaelle Derot, Andre Marini-Portugal, Bernard Maitre, et al.
RMD Open|December 19, 2023
Influence of sex on the persistence of different classes of targeted therapies for psoriatic arthritis: a cohort study of 14 778 patients from the French health insurance database (SNDS)Laura Pina Vegas, Laetitia Penso, Emilie Sbidian, et al.
Arthritis & Rheumatology (Hoboken, N.J.)|March 14, 2014
Effectiveness of tumor necrosis factor α blockers in early axial spondyloarthritis: data from the DESIR cohortAnna Moltó, Simon Paternotte, Pascal Claudepierre, et al.
Pageof 16